Britain#39;s GSK to take 10% stake in Germany#39;s CureVac for $163 million
CureVac#39;s existing COVID-19 mRNA and rabies vaccines research programmes are not included in the deal, the companies said.
from Moneycontrol Business News https://ift.tt/2WD8SQj
from Moneycontrol Business News https://ift.tt/2WD8SQj
No comments: